Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment

Damien Pouessel, Y. Neuzillet, Laura S. Mertens, Michiel S. van der Heijden, Joep de Jong, Joyce Sanders, Dennis Peters, Karen Leroy, Ambroise Manceau, Patrick Maillé, Pascale Soyeux, Anissa Moktefi, Fannie Semprez, Dimitri Vordos, Alexandre de la Taille, Carolyn D. Hurst, Darren C. Tomlinson, Patricia Harnden, Peter J. Boström, Tuomas Mirtti, Simon Horenblas, Yohann Loriot, Nadine Houédé, Christine Chevreau, P Beuzeboc, Shahrokh F. Shariat, Arthur I. Sagalowsky, Raheela Ashfaq, M. Bürger, Michael A.S. Jewett, A. Zlotta, Annegien Broeks, Bharati Bapat, Margaret A. Knowles, Y. Lotan, Theodorus van der Kwast, Stéphane Culine, Yves Allory, Bas W.G. van Rhijn

Annals of Oncology · 2016

Read source ↗ All evidence

Source type: Peer-reviewed study
DOI: 10.1093/annonc/mdw170
Catalogue ID: BFmoef2rp2-grdi5t

Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.

How does this finding apply in a UK context?→What are the most cited records on this topic?→